AEGiS-Chicago Tribune: Promising AIDS drug Chicago TribuneImportant note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
Click here to return to Chicago Tribune main menu
DonateNow


Promising AIDS drug

Chicago Tribune - April 17, 2007

A Spanish study reveals promising results for the new AIDS drug designed to help patients who are having the most trouble keeping the disease at bay. The drug darunavir appears to be 4.5 times more effective than existing regimens at reducing the level of the AIDS virus in the blood to near zero, the study found. Darunavir, known by the brand name Prezista, has been available in the United States since last summer.
070417
CT070407

Copyright © 2007 - Chicago Tribune. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Chicago Tribune, Permissions Desk, 435 North Michigan Avenue, Chicago, IL 60611  http://www.chicagotribune.com

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, the Elton John AIDS Foundation, National Library of Medicine, Pacific Life Foundation, and donations from users like you.

Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .